Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Kavalactones Protect Neural Cells against Amyloid β Peptide-Induced Neurotoxicity via Extracellular Signal-Regulated Kinase 1/2-Dependent Nuclear Factor Erythroid 2-Related Factor 2 Activation

Christoph J. Wruck, Mario E. Götz, Thomas Herdegen, Deike Varoga, Lars-Ove Brandenburg and Thomas Pufe
Molecular Pharmacology June 2008, 73 (6) 1785-1795; DOI: https://doi.org/10.1124/mol.107.042499
Christoph J. Wruck
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario E. Götz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Herdegen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deike Varoga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars-Ove Brandenburg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Pufe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 73 no. 6 1785-1795
DOI 
https://doi.org/10.1124/mol.107.042499
PubMed 
18334601

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received October 5, 2007
  • Accepted March 10, 2008
  • Published online May 20, 2008.

Article Versions

  • Earlier version (March 11, 2008 - 08:41).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Christoph J. Wruck,
  2. Mario E. Götz,
  3. Thomas Herdegen,
  4. Deike Varoga,
  5. Lars-Ove Brandenburg and
  6. Thomas Pufe
  1. Department of Anatomy and Cell Biology, University Hospital of Aachen, Aachen, Germany (C.J.W., L.-O.B., T.P.); and Institute of Pharmacology (M.E.G., T.H.) and Department of Trauma Surgery (D.V.), University Hospital of Schleswig-Holstein UK-SH, Kiel, Germany
  1. Address correspondence to:
    Dr. Christoph J. Wruck, Department of Anatomy and Cell Biology, RWTH Aachen, Wendlingweg 2, 52074 Aachen, Germany. E-mail: cwruck{at}ukaachen.de
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: March 2008 to March 2023

AbstractFullPdf
Mar 2008220168
Apr 2008260121
May 2008311172
Jun 2008605051
Jul 2008823038
Aug 2008701925
Sep 2008621315
Oct 2008491515
Nov 2008401421
Dec 2008281422
Jan 20092986
Feb 2009401619
Mar 2009441518
Apr 2009271716
May 200917910
Jun 2009155434
Jul 2009174852
Aug 2009163834
Sep 2009172922
Oct 2009122823
Nov 2009303128
Dec 2009271117
Jan 2010453237
Feb 2010212116
Mar 2010123841
Apr 2010273520
May 2010374123
Jun 2010233219
Jul 2010162718
Aug 2010733223
Sep 2010241612
Oct 2010122814
Nov 2010154022
Dec 2010132414
Jan 2011132330
Feb 2011172223
Mar 2011103126
Apr 2011281111
May 2011122125
Jun 201172619
Jul 2011252012
Aug 2011351816
Sep 2011204226
Oct 2011393923
Nov 2011273014
Dec 2011233922
Jan 2012313414
Feb 2012262216
Mar 2012222813
Apr 2012304130
May 2012352618
Jun 2012262413
Jul 2012433122
Aug 2012363423
Sep 2012293317
Oct 2012433432
Nov 2012403629
Dec 2012162414
Jan 2013222623
Feb 2013212211
Mar 2013202019
Apr 2013222318
May 2013222519
Jun 2013232311
Jul 2013132819
Aug 201319208
Sep 201318184
Oct 2013132517
Nov 201319184
Dec 201311197
Jan 2014151813
Feb 2014122919
Mar 2014182320
Apr 2014242218
May 201410248
Jun 2014111514
Jul 2014143532
Aug 201410102
Sep 2014161614
Oct 2014104133
Nov 2014191410
Dec 2014242112
Jan 201551910
Feb 2015151616
Mar 201519138
Apr 201518811
May 2015182416
Jun 201516156
Jul 201592119
Aug 2015251620
Sep 20151722
Oct 201511129
Nov 2015141614
Dec 201511116
Jan 2016251925
Feb 2016311530
Mar 2016171023
Apr 2016191113
May 2016101212
Jun 201691518
Jul 201616145
Aug 20168148
Sep 20161198
Oct 20164103
Nov 201611710
Dec 20165154
Jan 2017395
Feb 20173168
Mar 20170268
Apr 20175127
May 2017572212
Jun 20176186
Jul 20178237
Aug 201751010
Sep 201792418
Oct 20173199
Nov 201793022
Dec 20173137
Jan 20183187
Feb 201831711
Mar 201822610
Apr 20183304
May 20183259
Jun 20187197
Jul 201842720
Aug 20185256
Sep 20182354
Oct 201843111
Nov 201822213
Dec 20182477
Jan 20191417
Feb 20192724
Mar 20193883
Apr 20192812
May 20191434
Jun 20193119
Jul 20192003
Aug 20192001
Sep 20191501
Oct 20191914
Nov 20192901
Dec 20192904
Jan 20202610
Feb 20207122
Mar 20201421
Apr 20202141
May 20202122
Jun 20201901
Jul 2020823
Aug 2020803
Sep 20201700
Oct 20201121
Nov 20202113
Dec 20203115
Jan 20212244
Feb 20213334
Mar 20213553
Apr 20213210
May 20211621
Jun 20212152
Jul 20213115
Aug 20211324
Sep 2021952
Oct 20211953
Nov 20211832
Dec 20212124
Jan 20223212
Feb 20222611
Mar 20221610
Apr 202225211
May 20221414
Jun 20221410
Jul 20221613
Aug 20222122
Sep 20223110
Oct 20221630
Nov 20222935
Dec 20222811
Jan 20233210
Feb 20232131
Mar 20234100

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 73 (6)
Molecular Pharmacology
Vol. 73, Issue 6
1 Jun 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Kavalactones Protect Neural Cells against Amyloid β Peptide-Induced Neurotoxicity via Extracellular Signal-Regulated Kinase 1/2-Dependent Nuclear Factor Erythroid 2-Related Factor 2 Activation
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Kavalactones Protect Neural Cells against Amyloid β Peptide-Induced Neurotoxicity via Extracellular Signal-Regulated Kinase 1/2-Dependent Nuclear Factor Erythroid 2-Related Factor 2 Activation

Christoph J. Wruck, Mario E. Götz, Thomas Herdegen, Deike Varoga, Lars-Ove Brandenburg and Thomas Pufe
Molecular Pharmacology June 1, 2008, 73 (6) 1785-1795; DOI: https://doi.org/10.1124/mol.107.042499

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Kavalactones Protect Neural Cells against Amyloid β Peptide-Induced Neurotoxicity via Extracellular Signal-Regulated Kinase 1/2-Dependent Nuclear Factor Erythroid 2-Related Factor 2 Activation

Christoph J. Wruck, Mario E. Götz, Thomas Herdegen, Deike Varoga, Lars-Ove Brandenburg and Thomas Pufe
Molecular Pharmacology June 1, 2008, 73 (6) 1785-1795; DOI: https://doi.org/10.1124/mol.107.042499
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
  • Benzbromarone Relaxes Airway Smooth Muscle via BK Activation
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics